Si-Ware Systems' NeoSpectra™ business was established in 2015 and specializes in the design and manufacturing of Microelectromechanical Systems (MEMS) powered miniature Fourier Transform InfraRed (FT-IR) spectrometers, or spectral sensors. The first generation NeoSpectra sensors operate in wide spectral ranges in the Near InfraRed (NIR) region, enabling the analysis of various material properties with a single sensor. The sensors are constructed from low cost, robust, permanently aligned, and highly reproducible components. The core technology is based on semiconductor fabrication techniques promising unprecedented economies of scale. NeoSpectra sensors are the smallest and lowest cost spectral sensors enabling ubiquitous spectral sensing for all.
NeoSpectra sensors can be used in a wide variety of industries and markets including:
Si-Ware Systems is a fabless company with design and development headquartered in Cairo, Egypt. There are two subsidiary branches in Paris, France and Los Angeles, California. NeoSpectra sensors are manufactured through a top tier, world-wide supply chain and are available through sales representatives and distributors around the world.
Si-Ware Systems' NeoSpectra
3, Khaled Ibn Al-Waleed St. Sheraton, Heliopolis, Cairo, Egypt 11361
TELEPHONE
+20 222 68 47 04
E-MAILinfo@si-ware.com
WEB SITEwww.neospectra.com
NUMBER OF EMPLOYEES
153
YEAR FOUNDED
2015
USA: 3
Elsewhere: 150
An Interview with AES Mid-Career Award Recipient Jason Dwyer
July 25th 2024Jason Dwyer of the University of Rhode Island has been named the recipient of the American Electrophoresis Society’s Mid-Career Award, which honors exceptional contributions to the field of electrophoresis, microfluidics, and related areas by an individual who is currently in the middle of their career.
Glucose's Impact on Brain Cancer Cells Unveiled Through Raman Imaging
July 25th 2024Researchers have used Raman spectroscopy and chemometric methods to reveal how glucose affects normal and cancerous brain cell metabolism. Their findings highlight specific biomarkers that can distinguish metabolic changes, potentially aiding in cancer research and treatment.